BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jia HY, Ding F, Chen JY, Lian JS, Zhang YM, Zeng LY, Xiang DR, Yu L, Hu JH, Yu GD, Cai H, Lu YF, Zheng L, Li LJ, Yang YD. Early kidney injury during long-term adefovir dipivoxil therapy for chronic hepatitis B. World J Gastroenterol 2015; 21(12): 3657-3662 [PMID: 25834334 DOI: 10.3748/wjg.v21.i12.3657] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Qian YY, Dai ZJ, Ruan LY, Pan YJ, Jin J, Shi MT, Zhu YX, Wu CM. Low-dose adefovir dipivoxil-induced hypophosphatemia osteomalacia in five chronic hepatitis B virus-infected patients. Is low-dose adefovir dipivoxil-induced nephrotoxicity completely reversible? Drug Des Devel Ther 2019;13:1127-33. [PMID: 31118563 DOI: 10.2147/DDDT.S192632] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
2 Koda R, Tsuchida M, Iino N, Narita I. Hypophosphatemic Osteomalacia Associated with Adefovir-induced Fanconi Syndrome Initially Diagnosed as Diabetic Kidney Disease and Vitamin D Deficiency. Intern Med 2019;58:821-5. [PMID: 30333420 DOI: 10.2169/internalmedicine.1698-18] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
3 Carey I, Byrne R, Childs K, Horner M, Bruce M, Wang B, Dusheiko G, Agarwal K. Serum NGAL can act as an early renal safety biomarker during long-term nucleos(t)ide analogue antiviral therapy in chronic hepatitis B. J Viral Hepat 2018;25:1139-50. [PMID: 29660209 DOI: 10.1111/jvh.12916] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Xiang Q, Liu Z, Yu Y, Zhang H, Xie Q, Mu G, Zhang J, Cen X, Cui Y. Osteomalacia and renal failure due to Fanconi syndrome caused by long-term low-dose Adefovir Dipivoxil: a case report. BMC Pharmacol Toxicol 2020;21:43. [PMID: 32503675 DOI: 10.1186/s40360-020-00421-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Wu X, Cai S, Li Z, Zheng C, Xue X, Zeng J, Peng J. Potential effects of telbivudine and entecavir on renal function: a systematic review and meta-analysis. Virol J 2016;13:64. [PMID: 27062520 DOI: 10.1186/s12985-016-0522-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 35] [Article Influence: 4.5] [Reference Citation Analysis]
6 Ozoya OO, Sokol L, Dalia S. Hepatitis B Reactivation with Novel Agents in Non-Hodgkin's Lymphoma and Prevention Strategies. J Clin Transl Hepatol 2016;4:143-50. [PMID: 27350944 DOI: 10.14218/JCTH.2016.00005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
7 Sun L, Yi D, Sun W, Wang C. Retrospective analysis of the clinical characteristics of adefovir dipivoxil-induced Fanconi's syndrome in the Chinese population. J Clin Pharm Ther 2020;45:722-8. [PMID: 32406123 DOI: 10.1111/jcpt.13154] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Luo Q, Deng Y, Cheng F, Kang J, Zhong S, Zhang D, Zeng W. Relationship between nephrotoxicity and long-term adefovir dipivoxil therapy for chronic hepatitis B: A meta-analysis. Medicine (Baltimore) 2016;95:e5578. [PMID: 27977591 DOI: 10.1097/MD.0000000000005578] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
9 Chen N, Zhang JB, Zhang Q, Zhao YP, Li LY, Liu LW, Yu F, Yu X, Peng T, Tang KX. Adefovir dipivoxil induced hypophosphatemic osteomalacia in chronic hepatitis B: a comparative study of Chinese and foreign case series. BMC Pharmacol Toxicol 2018;19:23. [PMID: 29769119 DOI: 10.1186/s40360-018-0212-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Li Z, Shen C, Wang Y, Wang W, Zhao Q, Liu Z, Wang Y, Zhao C. Circulating kidney injury molecule-1 is a novel diagnostic biomarker for renal dysfunction during long-term adefovir therapy in chronic hepatitis B. Medicine (Baltimore) 2016;95:e5264. [PMID: 27858892 DOI: 10.1097/MD.0000000000005264] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
11 Patricio JA, Lopes PF, Medeiros T, Mendes GF, Silva AA, Esberard EB, Lugon JR, Almeida JR. Tenofovir monotherapy for hepatitis B after 1 year does not produce renal dysfunction, but is associated with hyperparathyroidism not related to vitamin D. Eur J Gastroenterol Hepatol. 2016;28:64-69. [PMID: 26545084 DOI: 10.1097/MEG.0000000000000509] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
12 Song K, Yan Q, Yang Y, Lv M, Chen Y, Dai Y, Zhang L, Huang Y, Zhang C, Gao H. Fanconi syndrome induced by adefovir dipivoxil: a case report and clinical review. J Int Med Res 2020;48:300060520954713. [PMID: 33100076 DOI: 10.1177/0300060520954713] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]